NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · IEX Real-Time Price · USD
0.164
+0.015 (9.77%)
At close: May 17, 2024, 4:00 PM
0.165
+0.001 (0.55%)
After-hours: May 17, 2024, 7:48 PM EDT
NLS Pharmaceutics AG Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for NLSP.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for NLSP is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 14, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $4 | Hold → Strong Buy | Upgrades | $4 | +2,339.02% | Dec 8, 2022 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2022 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +3,558.54% | Sep 6, 2022 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Mar 12, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.62
from -0.84
EPS Next Year
-0.46
from -0.62
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -0.64 | -0.47 | -0.47 |
| Avg | -0.62 | -0.46 | -0.46 |
| Low | -0.60 | -0.44 | -0.44 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.